194 related articles for article (PubMed ID: 182633)
1. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
[TBL] [Abstract][Full Text] [Related]
2. Long-term treatment of acromegaly with Sandostatin (SMS 201-995). Normalization of most anomalous growth hormone responses.
Pieters GF; van Liessum PA; Smals AG; van Gennep JA; Benraad TJ; Kloppenborg PW
Acta Endocrinol Suppl (Copenh); 1987; 286():9-18. PubMed ID: 2892339
[TBL] [Abstract][Full Text] [Related]
3. Growth hormone and changes in the secretion of thyrotropic hormone after thyrotropin-releasing hormone (TRH): ineffectiveness of dopaminergic stimulation.
Felt V; Nedvídková J
Endokrinologie; 1982 Oct; 80(2):201-6. PubMed ID: 6819130
[No Abstract] [Full Text] [Related]
4. [Therapy of acromegaly using bromocriptine].
Köbberling J; Schwinn G; Dirks H
Dtsch Med Wochenschr; 1975 Jul; 100(29):1540-2. PubMed ID: 1149634
[TBL] [Abstract][Full Text] [Related]
5. Bromocriptine treatment of acromegaly: possible dose dependency of the tumor size-reducing effect.
Gross DJ; Halperin Y; Gomori JM; Glaser B
Isr J Med Sci; 1989 May; 25(5):256-60. PubMed ID: 2498229
[TBL] [Abstract][Full Text] [Related]
6. Treatment of acromegaly with bromocryptine.
Summers VK; Hipkin LJ; Diver MH; Davis JC
J Clin Endocrinol Metab; 1975 May; 40(5):904-6. PubMed ID: 1127097
[TBL] [Abstract][Full Text] [Related]
7. Effect of long term bromocriptine treatment on glucose intolerance in acromegaly.
Chiba T; Chihara K; Minamitani N; Goto B; Kadowaki S; Taminato T; Matsukura S; Fujita T
Horm Metab Res; 1982 Feb; 14(2):57-61. PubMed ID: 7040191
[TBL] [Abstract][Full Text] [Related]
8. [Determination of growth hormone response to thyreoliberin in the evaluation of lisuride therapy of acromegaly].
Felt V; Nedvídková J
Vnitr Lek; 1982 Aug; 28(8):756-61. PubMed ID: 6814061
[No Abstract] [Full Text] [Related]
9. Long-term bromocriptine treatment and somatostatin in acromegaly.
Gáspár L; László FA
Endokrinologie; 1980 Oct; 76(2):152-62. PubMed ID: 6108852
[TBL] [Abstract][Full Text] [Related]
10. Effect of bromocryptine on the secretion of thyrotropic hormone (TSH), prolactin (Pr), human growth hormone (HGH), thyroxine (T4) and triiodothyroxine (T3) in hypothyroidism.
Felt V; Nedvdková J
Horm Metab Res; 1977 Jul; 9(4):274-7. PubMed ID: 408253
[TBL] [Abstract][Full Text] [Related]
11. Treatment of acromegaly with bromocryptine.
Steinbeck K; Turtle JR
Aust N Z J Med; 1979 Jun; 9(3):217-24. PubMed ID: 288386
[TBL] [Abstract][Full Text] [Related]
12. [Long-term treatment of acromegaly with the somatostatin analog octreotide (Sandostatin). On the predictive significance of acute tests].
Schmidt K; Althoff PH; Harris A; Hofmeister-Wagner W; Schifferdecker E; Schöffling K
Med Klin (Munich); 1990 Dec; 85(12):700-6. PubMed ID: 2128367
[TBL] [Abstract][Full Text] [Related]
13. TRH/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients.
Brockmeier SJ; Buchfelder M; Fahlbusch R
Horm Metab Res; 1993 May; 25(5):275-7. PubMed ID: 8330864
[TBL] [Abstract][Full Text] [Related]
14. Conventional pituitary irradiation in acromegaly. Effect on growth hormone and TSH secretion.
Lamberg BA; Kivikangas V; Vartianen J; Raitta C; Pelkonen R
Acta Endocrinol (Copenh); 1976 Jun; 82(2):267-81. PubMed ID: 818860
[TBL] [Abstract][Full Text] [Related]
15. Bromocriptine therapy in acromegaly.
Sachdev Y; Gomez-Pan A; Tunbridge WM; Duns A; Weightman DR; Hall R; Goolamali SK
Lancet; 1975 Dec; 2(7946):1164-8. PubMed ID: 53655
[TBL] [Abstract][Full Text] [Related]
16. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
17. [Hormonal evaluation of 27 patients with acromegaly].
Villabona C; Novials A; Soler J; Morató J; Gómez JM; Navarro MA
Med Clin (Barc); 1985 Feb; 84(6):219-22. PubMed ID: 3920452
[No Abstract] [Full Text] [Related]
18. Bromocriptine therapy in eleven patients with acromegaly.
Lundin L; Ljunghall S; Wide L; Boström H
Acta Endocrinol Suppl (Copenh); 1978; 216():207-16. PubMed ID: 347863
[TBL] [Abstract][Full Text] [Related]
19. Paradoxic elevation in serum GH by hypothalamic releasing hormones predicts GH response to acute SMS 201-995 administration.
Candrina R
Recenti Prog Med; 1991 Jan; 82(1):13-6. PubMed ID: 1902962
[TBL] [Abstract][Full Text] [Related]
20. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
Besser GM; Wass JA
Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
